Results 261 to 270 of about 347,807 (336)

First‐time cefuroxime target tissue concentrations in long‐lasting spine surgery: Continuous evaluation after repeated weight‐dosed administrations

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Antimicrobial prophylaxis is central in preventing postoperative spine infections, yet knowledge on clinical target spine tissue concentrations remain limited. Current dosing regimens often involve fixed doses based on empirical knowledge, surrogate measures, non‐clinical evidence and methodology of variying quality.
Magnus Andreas Hvistendahl   +6 more
wiley   +1 more source

Population pharmacokinetics and optimized dosing of cefuroxime in critically ill patients

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Cefuroxime is a second‐generation cephalosporin widely used in the intensive care unit (ICU). ICU patients have high variability in interpatient pharmacokinetics (PK), but the extent of this variation is unclear. We performed an observational PK study in ICU patients.
Jaap W. A. Mouton   +9 more
wiley   +1 more source

A novel approach for urethral catheterization in dromedary camels: a preclinical study. [PDF]

open access: yesBMC Vet Res
Marzok M   +5 more
europepmc   +1 more source

Optical Coherence Tomography for Cervical Artery Dissection

open access: yes
Annals of Neurology, EarlyView.
Guangxun Shen   +3 more
wiley   +1 more source

Optimizing Peripheral Nerve Block Placement in Hip Surgery: A Cadaveric Study Mapping the Posterior Cutaneous Innervation

open access: yesClinical Anatomy, EarlyView.
ABSTRACT Optimizing analgesia after hip surgery enables more rapid recovery. However, peripheral nerve blocks (PNBs) often fail to provide adequate pain relief in the posterolateral hip as they typically target the lateral cutaneous nerve of the thigh (LCNT).
Ziki Gurney   +5 more
wiley   +1 more source

Subtyping of Primary Aldosteronism by Adrenal Venous Sampling.

open access: yesEndocr Rev
Rossi GP   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy